Ono Pharma Korea said Monday that it appointed Yang Min-yeol as its new chief executive officer. The new CEO will start work from Sept. 1.
|Ono Pharma Korea CEO Yang Min-yeol|
After graduating from Seoul National University, Yang worked at Eisai Korea before joining Ono Pharma Korea as vice president in 2014. After joining the company, Yang contributed significantly to the launch and reimbursement of Opdivio – an immune-oncology treatment -- in Korea.
“I am delighted to dedicate myself to a company that continuously researches and develops medicines that benefit patients,” Yang said. “I will do my best for the company and patients by conducting more competitive research and development.”
Ono Pharma Korea was established in December 2013 as a subsidiary of Ono Pharmaceuticals in Japan.
<© Korea Biomedical Review, All rights reserved.>